LAMEA Monoclonal Antibodies In Veterinary Health Market Size, Share & Industry Analysis Report By Animal Type (Dogs and Other Animal Type), By Scope (Dermatology, Pain, and Other Scope), By End User (Veterinary Hospitals and Other End User), By Country and Growth Forecast, 2025 - 2032
Published Date : 07-Jul-2025 |
Pages: 151 |
Report Format: PDF + Excel |
COVID-19 Impact on the LAMEA Monoclonal Antibodies In Veterinary Health Market
Market Overview
The Latin America, Middle East and Africa Monoclonal Antibodies In Veterinary Health Market would witness market growth of 19.8% CAGR during the forecast period (2025-2032).
The Brazil market dominated the LAMEA Monoclonal Antibodies In Veterinary Health Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $105.9 million by 2032. The Argentina market is showcasing a CAGR of 21.2% during (2025 - 2032). Additionally, The UAE market would register a CAGR of 18.4% during (2025 - 2032).
The LAMEA region is witnessing a growing shift towards the adoption of monoclonal antibodies (mAbs) in veterinary health, driven by increasing awareness of animal welfare and a rising demand for effective, targeted treatments. In many urban centers across Latin America and the Middle East, companion animal ownership has surged, leading to increased veterinary visits and demand for innovative therapies.
Monoclonal antibodies, known for their precision and long-acting effects, are gradually replacing conventional therapies in treating conditions like osteoarthritis, chronic inflammation, and dermatological disorders in dogs and cats. This shift indicates a trend toward modernization in veterinary care across the region. One major trend in LAMEA is the expansion of veterinary biologic manufacturing and technology transfer.
Brazil represents the largest veterinary monoclonal antibody (mAb) market in Latin America, driven by rapid urbanization, increasing pet adoption, and a modernizing animal healthcare sector. Companion animal ownership, particularly dogs, has soared in recent years, aligning with a growing preference for advanced veterinary care. This transformation has positioned mAbs as a critical therapeutic innovation, especially for chronic inflammatory and dermatologic conditions in canines. The country's veterinary clinics and hospitals are increasingly equipped with diagnostic tools and treatment capabilities that facilitate biologic therapy administration.
Argentina's monoclonal antibodies market for veterinary health is a developing segment within Latin America. With increasing awareness about pet health and a growing base of companion animal owners, the country shows a steady rise in demand for biologic therapies. Pet humanization is a key driver, particularly in urban centers like Buenos Aires and Córdoba, where pet owners are increasingly investing in premium care solutions. While veterinary infrastructure in rural areas remains uneven, major cities have witnessed substantial growth in private clinics offering cutting-edge treatments such as mAb therapy.
The UAE’s monoclonal antibodies market in veterinary health is in a rapid growth phase, fueled by high pet ownership rates among expatriates and affluent Emirati families. The country’s well-developed veterinary infrastructure, with numerous advanced pet clinics and hospitals, provides a strong foundation for the introduction and adoption of biologic therapies like monoclonal antibodies. Pet humanization trends, especially in cities like Dubai and Abu Dhabi, have made owners increasingly receptive to high-value treatments that offer precision care, especially for dermatological and orthopedic conditions. Thus, LAMEA remains an emerging market where limited infrastructure and regulatory variability present challenges, but urbanization and rising animal health concerns are fostering gradual growth.
Free Valuable Insights: The Worldwide Monoclonal Antibodies In Veterinary Health Market is Projected to reach USD 4.33 Billion by 2032, at a CAGR of 18.5%
Based on Animal Type, the market is segmented into Dogs and Other Animal Type. Based on Scope, the market is segmented into Dermatology, Pain, and Other Scope. Based on End User, the market is segmented into Veterinary Hospitals and Other End User. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Zoetis, Inc.
- Virbac
- Merck KGaA
- Elanco Animal Health, Inc.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Phibro Animal Health Corporation
- Indian Immunologicals Ltd.
LAMEA Monoclonal Antibodies In Veterinary Health Market Report Segmentation
By Animal Type
- Dogs
- Other Animal Type
By Scope
- Dermatology
- Pain
- Other Scope
By End User
- Veterinary Hospitals
- Other End User
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
1.4.2 LAMEA Monoclonal Antibodies In Veterinary Health Market, by Scope
1.4.3 LAMEA Monoclonal Antibodies In Veterinary Health Market, by End User
1.4.4 LAMEA Monoclonal Antibodies In Veterinary Health Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
4.1 Research & Development (R&D)
4.2 Regulatory & Clinical Trials
4.3 Technology Transfer & Process Validation
4.4 Manufacturing
4.5 Packaging & Distribution
4.6 Marketing & Veterinary Engagement
4.7 Post-Market Surveillance & Pharmacovigilance
4.8 Customer Feedback & Support
Chapter 5. Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
Chapter 6. LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type
6.1 LAMEA Dogs Market by Country
6.2 LAMEA Other Animal Type Market by Country
Chapter 7. LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope
7.1 LAMEA Dermatology Market by Country
7.2 LAMEA Pain Market by Country
7.3 LAMEA Other Scope Market by Country
Chapter 8. LAMEA Monoclonal Antibodies In Veterinary Health Market by End User
8.1 LAMEA Veterinary Hospitals Market by Country
8.2 LAMEA Other End User Market by Country
Chapter 9. LAMEA Monoclonal Antibodies In Veterinary Health Market by Country
9.1 Brazil Monoclonal Antibodies In Veterinary Health Market
9.1.1 Brazil Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.1.2 Brazil Monoclonal Antibodies In Veterinary Health Market by Scope
9.1.3 Brazil Monoclonal Antibodies In Veterinary Health Market by End User
9.2 Argentina Monoclonal Antibodies In Veterinary Health Market
9.2.1 Argentina Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.2.2 Argentina Monoclonal Antibodies In Veterinary Health Market by Scope
9.2.3 Argentina Monoclonal Antibodies In Veterinary Health Market by End User
9.3 UAE Monoclonal Antibodies In Veterinary Health Market
9.3.1 UAE Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.3.2 UAE Monoclonal Antibodies In Veterinary Health Market by Scope
9.3.3 UAE Monoclonal Antibodies In Veterinary Health Market by End User
9.4 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market
9.4.1 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.4.2 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Scope
9.4.3 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by End User
9.5 South Africa Monoclonal Antibodies In Veterinary Health Market
9.5.1 South Africa Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.5.2 South Africa Monoclonal Antibodies In Veterinary Health Market by Scope
9.5.3 South Africa Monoclonal Antibodies In Veterinary Health Market by End User
9.6 Nigeria Monoclonal Antibodies In Veterinary Health Market
9.6.1 Nigeria Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.6.2 Nigeria Monoclonal Antibodies In Veterinary Health Market by Scope
9.6.3 Nigeria Monoclonal Antibodies In Veterinary Health Market by End User
9.7 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market
9.7.1 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.7.2 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope
9.7.3 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by End User
Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Partnerships, Collaborations, and Agreements:
10.2.5 SWOT Analysis
10.3 Merck KGaA
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 SWOT Analysis
10.4 Elanco Animal Health, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Boehringer Ingelheim International GmbH
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ceva Sante Animale
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 Phibro Animal Health Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Indian Immunologicals Ltd.
10.8.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
1.4.2 LAMEA Monoclonal Antibodies In Veterinary Health Market, by Scope
1.4.3 LAMEA Monoclonal Antibodies In Veterinary Health Market, by End User
1.4.4 LAMEA Monoclonal Antibodies In Veterinary Health Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
4.1 Research & Development (R&D)
4.2 Regulatory & Clinical Trials
4.3 Technology Transfer & Process Validation
4.4 Manufacturing
4.5 Packaging & Distribution
4.6 Marketing & Veterinary Engagement
4.7 Post-Market Surveillance & Pharmacovigilance
4.8 Customer Feedback & Support
Chapter 5. Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
Chapter 6. LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type
6.1 LAMEA Dogs Market by Country
6.2 LAMEA Other Animal Type Market by Country
Chapter 7. LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope
7.1 LAMEA Dermatology Market by Country
7.2 LAMEA Pain Market by Country
7.3 LAMEA Other Scope Market by Country
Chapter 8. LAMEA Monoclonal Antibodies In Veterinary Health Market by End User
8.1 LAMEA Veterinary Hospitals Market by Country
8.2 LAMEA Other End User Market by Country
Chapter 9. LAMEA Monoclonal Antibodies In Veterinary Health Market by Country
9.1 Brazil Monoclonal Antibodies In Veterinary Health Market
9.1.1 Brazil Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.1.2 Brazil Monoclonal Antibodies In Veterinary Health Market by Scope
9.1.3 Brazil Monoclonal Antibodies In Veterinary Health Market by End User
9.2 Argentina Monoclonal Antibodies In Veterinary Health Market
9.2.1 Argentina Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.2.2 Argentina Monoclonal Antibodies In Veterinary Health Market by Scope
9.2.3 Argentina Monoclonal Antibodies In Veterinary Health Market by End User
9.3 UAE Monoclonal Antibodies In Veterinary Health Market
9.3.1 UAE Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.3.2 UAE Monoclonal Antibodies In Veterinary Health Market by Scope
9.3.3 UAE Monoclonal Antibodies In Veterinary Health Market by End User
9.4 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market
9.4.1 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.4.2 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Scope
9.4.3 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by End User
9.5 South Africa Monoclonal Antibodies In Veterinary Health Market
9.5.1 South Africa Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.5.2 South Africa Monoclonal Antibodies In Veterinary Health Market by Scope
9.5.3 South Africa Monoclonal Antibodies In Veterinary Health Market by End User
9.6 Nigeria Monoclonal Antibodies In Veterinary Health Market
9.6.1 Nigeria Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.6.2 Nigeria Monoclonal Antibodies In Veterinary Health Market by Scope
9.6.3 Nigeria Monoclonal Antibodies In Veterinary Health Market by End User
9.7 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market
9.7.1 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type
9.7.2 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope
9.7.3 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by End User
Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Partnerships, Collaborations, and Agreements:
10.2.5 SWOT Analysis
10.3 Merck KGaA
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 SWOT Analysis
10.4 Elanco Animal Health, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Boehringer Ingelheim International GmbH
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ceva Sante Animale
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 Phibro Animal Health Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Indian Immunologicals Ltd.
10.8.1 Company Overview
List of Tables
TABLE 1 LAMEA Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 2 LAMEA Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 3 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
TABLE 4 LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 5 LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 6 LAMEA Dogs Market by Country, 2021 - 2024, USD Million
TABLE 7 LAMEA Dogs Market by Country, 2025 - 2032, USD Million
TABLE 8 LAMEA Other Animal Type Market by Country, 2021 - 2024, USD Million
TABLE 9 LAMEA Other Animal Type Market by Country, 2025 - 2032, USD Million
TABLE 10 Use Case 1: Canine Monoclonal Antibody Therapies – Targeted Treatment Innovations for Dogs
TABLE 11 Use Case 2: Monoclonal Antibodies for Livestock & Exotic Animals – Immune-Driven Disease Control
TABLE 12 LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 13 LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 14 LAMEA Dermatology Market by Country, 2021 - 2024, USD Million
TABLE 15 LAMEA Dermatology Market by Country, 2025 - 2032, USD Million
TABLE 16 LAMEA Pain Market by Country, 2021 - 2024, USD Million
TABLE 17 LAMEA Pain Market by Country, 2025 - 2032, USD Million
TABLE 18 LAMEA Other Scope Market by Country, 2021 - 2024, USD Million
TABLE 19 LAMEA Other Scope Market by Country, 2025 - 2032, USD Million
TABLE 20 Use Case 1: Targeted Monoclonal Antibody Therapy for Canine Dermatological Conditions
TABLE 21 Use Case 2: Monoclonal Antibody-Based Pain Management in Veterinary Orthopedic Care
TABLE 22 Use Case 3: Monoclonal Antibodies for Veterinary Oncology, Immune Modulation & Infectious Disease
TABLE 23 LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 24 LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 25 LAMEA Veterinary Hospitals Market by Country, 2021 - 2024, USD Million
TABLE 26 LAMEA Veterinary Hospitals Market by Country, 2025 - 2032, USD Million
TABLE 27 LAMEA Other End User Market by Country, 2021 - 2024, USD Million
TABLE 28 LAMEA Other End User Market by Country, 2025 - 2032, USD Million
TABLE 29 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2024, USD Million
TABLE 30 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2025 - 2032, USD Million
TABLE 31 Brazil Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 32 Brazil Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 33 Brazil Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 34 Brazil Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 35 Brazil Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 36 Brazil Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 37 Brazil Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 38 Brazil Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 39 Argentina Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 40 Argentina Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 41 Argentina Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 42 Argentina Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 43 Argentina Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 44 Argentina Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 45 Argentina Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 46 Argentina Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 47 UAE Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 48 UAE Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 49 UAE Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 50 UAE Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 51 UAE Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 52 UAE Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 53 UAE Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 54 UAE Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 55 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 56 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 57 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 58 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 59 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 60 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 61 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 62 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 63 South Africa Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 64 South Africa Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 65 South Africa Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 66 South Africa Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 67 South Africa Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 68 South Africa Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 69 South Africa Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 70 South Africa Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 71 Nigeria Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 72 Nigeria Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 73 Nigeria Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 74 Nigeria Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 75 Nigeria Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 76 Nigeria Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 77 Nigeria Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 78 Nigeria Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 79 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 80 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 81 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 82 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 83 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 84 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 85 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 86 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 87 Key Information – Zoetis, Inc.
TABLE 88 Key Information – Virbac
TABLE 89 key Information – Merck KGaA
TABLE 90 Key information – Elanco Animal Health, Inc.
TABLE 91 Key Information – Boehringer Ingelheim International GmbH
TABLE 92 Key Information – Ceva SantE Animale
TABLE 93 Key Information – Phibro Animal Health Corporation
TABLE 94 Key Information – Indian Immunologicals Ltd
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Monoclonal Antibodies In Veterinary Health Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Monoclonal Antibodies In Veterinary Health Market
FIG 4 Porter’s Five Forces Analysis – Monoclonal Antibodies In Veterinary Health Market
FIG 5 Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
FIG 6 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
FIG 7 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2024
FIG 8 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2032
FIG 9 LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2032, USD Million
FIG 10 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Scope, 2024
FIG 11 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Scope, 2032
FIG 12 LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2032, USD Million
FIG 13 LAMEA Monoclonal Antibodies In Veterinary Health Market share by End User, 2024
FIG 14 LAMEA Monoclonal Antibodies In Veterinary Health Market share by End User, 2032
FIG 15 LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2032, USD Million
FIG 16 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Country, 2024
FIG 17 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2032
FIG 18 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2032, USD Million
FIG 19 Swot Analysis: ZOETIS, INC.
FIG 20 SWOT Analysis: Virbac
FIG 21 Swot Analysis: Merck KGaA
FIG 22 SWOT Analysis: Elanco Animal Health, Inc.
FIG 23 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 24 SWOT Analysis: Ceva Sante Animale
TABLE 2 LAMEA Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 3 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
TABLE 4 LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 5 LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 6 LAMEA Dogs Market by Country, 2021 - 2024, USD Million
TABLE 7 LAMEA Dogs Market by Country, 2025 - 2032, USD Million
TABLE 8 LAMEA Other Animal Type Market by Country, 2021 - 2024, USD Million
TABLE 9 LAMEA Other Animal Type Market by Country, 2025 - 2032, USD Million
TABLE 10 Use Case 1: Canine Monoclonal Antibody Therapies – Targeted Treatment Innovations for Dogs
TABLE 11 Use Case 2: Monoclonal Antibodies for Livestock & Exotic Animals – Immune-Driven Disease Control
TABLE 12 LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 13 LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 14 LAMEA Dermatology Market by Country, 2021 - 2024, USD Million
TABLE 15 LAMEA Dermatology Market by Country, 2025 - 2032, USD Million
TABLE 16 LAMEA Pain Market by Country, 2021 - 2024, USD Million
TABLE 17 LAMEA Pain Market by Country, 2025 - 2032, USD Million
TABLE 18 LAMEA Other Scope Market by Country, 2021 - 2024, USD Million
TABLE 19 LAMEA Other Scope Market by Country, 2025 - 2032, USD Million
TABLE 20 Use Case 1: Targeted Monoclonal Antibody Therapy for Canine Dermatological Conditions
TABLE 21 Use Case 2: Monoclonal Antibody-Based Pain Management in Veterinary Orthopedic Care
TABLE 22 Use Case 3: Monoclonal Antibodies for Veterinary Oncology, Immune Modulation & Infectious Disease
TABLE 23 LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 24 LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 25 LAMEA Veterinary Hospitals Market by Country, 2021 - 2024, USD Million
TABLE 26 LAMEA Veterinary Hospitals Market by Country, 2025 - 2032, USD Million
TABLE 27 LAMEA Other End User Market by Country, 2021 - 2024, USD Million
TABLE 28 LAMEA Other End User Market by Country, 2025 - 2032, USD Million
TABLE 29 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2024, USD Million
TABLE 30 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2025 - 2032, USD Million
TABLE 31 Brazil Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 32 Brazil Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 33 Brazil Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 34 Brazil Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 35 Brazil Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 36 Brazil Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 37 Brazil Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 38 Brazil Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 39 Argentina Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 40 Argentina Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 41 Argentina Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 42 Argentina Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 43 Argentina Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 44 Argentina Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 45 Argentina Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 46 Argentina Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 47 UAE Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 48 UAE Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 49 UAE Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 50 UAE Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 51 UAE Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 52 UAE Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 53 UAE Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 54 UAE Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 55 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 56 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 57 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 58 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 59 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 60 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 61 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 62 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 63 South Africa Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 64 South Africa Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 65 South Africa Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 66 South Africa Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 67 South Africa Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 68 South Africa Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 69 South Africa Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 70 South Africa Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 71 Nigeria Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 72 Nigeria Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 73 Nigeria Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 74 Nigeria Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 75 Nigeria Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 76 Nigeria Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 77 Nigeria Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 78 Nigeria Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 79 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 80 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 81 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 82 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 83 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 84 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 85 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 86 Rest of LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 87 Key Information – Zoetis, Inc.
TABLE 88 Key Information – Virbac
TABLE 89 key Information – Merck KGaA
TABLE 90 Key information – Elanco Animal Health, Inc.
TABLE 91 Key Information – Boehringer Ingelheim International GmbH
TABLE 92 Key Information – Ceva SantE Animale
TABLE 93 Key Information – Phibro Animal Health Corporation
TABLE 94 Key Information – Indian Immunologicals Ltd
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Monoclonal Antibodies In Veterinary Health Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Monoclonal Antibodies In Veterinary Health Market
FIG 4 Porter’s Five Forces Analysis – Monoclonal Antibodies In Veterinary Health Market
FIG 5 Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
FIG 6 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
FIG 7 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2024
FIG 8 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2032
FIG 9 LAMEA Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2032, USD Million
FIG 10 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Scope, 2024
FIG 11 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Scope, 2032
FIG 12 LAMEA Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2032, USD Million
FIG 13 LAMEA Monoclonal Antibodies In Veterinary Health Market share by End User, 2024
FIG 14 LAMEA Monoclonal Antibodies In Veterinary Health Market share by End User, 2032
FIG 15 LAMEA Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2032, USD Million
FIG 16 LAMEA Monoclonal Antibodies In Veterinary Health Market share by Country, 2024
FIG 17 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2032
FIG 18 LAMEA Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2032, USD Million
FIG 19 Swot Analysis: ZOETIS, INC.
FIG 20 SWOT Analysis: Virbac
FIG 21 Swot Analysis: Merck KGaA
FIG 22 SWOT Analysis: Elanco Animal Health, Inc.
FIG 23 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 24 SWOT Analysis: Ceva Sante Animale